Deputy awarded for helping save child's life
DAYTON, Ohio (WDTN) — A Mercer County Sheriff's Deputy was recently recognized for the life-saving action he took to save a child's life.
Deputy and Corrections Officer Chad Etzler was home, off-duty from his shift on the evening of April 21. Soon enough, a neighbor ran to him saying that they thought their infant child was choking.
Etzler performed CPR on the child until EMS crews arrived and transported the child to an area hospital.
Medical staff later determined that the child was suffering from an episode related to Sudden Infant Death Syndrome.
'Thanks to the quick thinking and actions by Chad, that child`s life was saved,' said Sheriff Doug Timmerman in a release via social media.
Etzler received the 'Life Saving Award' for his efforts.
Photo courtesy of the Mercer County Sheriff's Office.
Copyright 2025 Nexstar Media, Inc. All rights reserved. This material may not be published, broadcast, rewritten, or redistributed.
For the latest news, weather, sports, and streaming video, head to WDTN.com.
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Medscape
35 minutes ago
- Medscape
Merck's Potential Blockbuster Cholesterol Pill Succeeds in Late-stage Studies
(Reuters) -Merck's oral cholesterol pill succeeded in two late-stage studies, marking a win for the drugmaker as it focuses on the development of growth drivers beyond its cancer drugs and vaccines. The company is searching for its next blockbuster candidate as its major revenue driver, Keytruda, is expected to lose patent protection by the end of the decade. Merck's non-statin cholesterol drug, enlicitide decanoate, is being tested for the treatment of hyperlipidemia, a condition that causes elevated buildup of fat in the blood vessels and can lead to heart attacks and strokes. Enlicitide works by blocking PCSK9, a protein that plays a crucial role in regulating cholesterol levels, while statins block an enzyme the liver uses to make cholesterol. BMO Capital Markets analyst Evan Seigerman said Merck's drug could potentially provide a "multi-billion dollar opportunity" that expands the PCSK9 market beyond current injectable therapies. The drug showed meaningful reductions in LDL-C cholesterol, commonly referred to as "bad cholesterol", when compared to placebo and other oral non-statin therapies, Merck said. However, Leerink analysts have noted that Astrazeneca's AZD0780 is a "credible threat" as it has shown a 50.7% reduction in LDL-C levels during a trial. Merck has not given the details on LDL-C reduction for enlicitide. The drug was tested in patients who have a history of, or are at risk for a type of heart disease, and were treated with a statin. Shares of Merck were up 2% in premarket trading. Verve Therapeutics is also developing a gene therapy to reduce high cholesterol levels, which is expected to be used in combination with other drugs. (Reporting by Christy Santhosh in Bengaluru; Editing by Shinjini Ganguli)
New York Times
an hour ago
- New York Times
Trump Budget's Caps on Grad School Loans Could Worsen Doctor Shortage
President Trump's proposed budget would make deep cuts in government health plans and medical research, and, critics say, could also make finding a doctor more difficult: It restricts loans that students rely on to pursue professional graduate degrees, making the path to becoming a physician harder even as doctor shortages loom and the American population is graying. The domestic policy bill, which passed in the House last month, would cap direct federal unsubsidized loans at $150,000 — far less than the cost of obtaining a medical education — and phase out the Grad PLUS loans that help many students make up the difference. Medicine, dentistry and osteopathic medicine are among the most expensive graduate programs. Four years of medical education costs $286,454 at a public school, on average, and $390,848 at a private one, according to the Association of American Medical Colleges. Medical school graduates leave with an average debt of $212,341, the association found. The price of a four-year program in osteopathic medicine is $297,881 at a public school, on average, and $371,403 at a private school, according to the American Association of Colleges of Osteopathic Medicine. The average indebtedness of their graduates is $259,196. The proposed loan caps 'will either push students and families into the private loan market, where they take on more risk and have less consumer protection, or simply push people out of higher education altogether,' said Aissa Canchola Bañez, policy director at the Student Borrower Protection Center, a nonprofit advocacy group. Private student loans are also not eligible for Public Service Loan Forgiveness programs, which many students rely on to manage their debt. Students from low-income families may have difficulty qualifying for private loans. Want all of The Times? Subscribe.
CBS News
an hour ago
- CBS News
Salmonella outbreak tied to recalled eggs makes dozens sick across 7 states in the West and Midwest
A salmonella outbreak linked to a large egg recall has made dozens of people sick in seven states in the West and Midwest, federal health officials said Saturday. The August Egg Company recalled about 1.7 million brown organic and brown cage-free egg varieties distributed to grocery stores between February and May because of the potential for salmonella, according to an announcement posted Friday on the Food and Drug Administration's website. At least 79 people in seven states have gotten a strain of salmonella that was linked to the eggs, and 21 people have been hospitalized, the Centers for Disease Control and Prevention said. The recall affects retailers in Arizona, California, Illinois, Indiana, Nebraska, New Mexico, Nevada, Washington and Wyoming. The recalled eggs were sold under brand names including Clover, First Street, Nulaid, O Organics, Marketside, Raleys, Simple Truth, Sun Harvest, and Sunnyside. Plant code numbers for the recalled eggs are P-6562 or CA5330, according to the CDC's website. This Centers for Disease Control and Prevention map shows the locations of people affected by a Salmonella outbreak linked to eggs. Centers for Disease Control and Prevention "August Egg Company's internal food safety team also is conducting its own stringent review to identify what measures can be established to prevent this situation from recurring," the company said in a statement on the FDA's website. "We are committed to addressing this matter fully and to implementing all necessary corrective actions to ensure this does not happen again." Symptoms of salmonella poisoning include diarrhea, fever, severe vomiting, dehydration and stomach cramps. Most people who get sick recover within a week. Infections can be severe in young children, older adults and people with weakened immune systems, who may require hospitalization. The CDC advises people to throw away recalled eggs or return them to the store where they were purchased. Consumers should also wash and disinfect any surfaces that came in contact with the eggs. This is the latest in a string of salmonella-related outbreaks recently involving food. A tomato recall affecting three southern states was upgraded to a Class I recall, the most severe warning by the Food and Drug Administration. The recall was first announced in May over potential salmonella contamination. Also, nearly four dozen people across 18 states have gotten sick with salmonella food poisoning tied to recalled cucumbers, according to federal health officials. In an update, the CDC said the expanding outbreak led to at least 16 people being hospitalized.
